“For the first time, the company says it has successfully hatched live chicks carrying edited traits linked to extinct birds.”
A biotechnology startup working on de-extinction research has announced a breakthrough that is making the internet compare real science to “Jurassic Park” again. Colossal Biosciences, the company already known for its controversial efforts to revive extinct animals like the woolly mammoth and Tasmanian tiger, says it has now successfully hatched live chicks carrying genetically edited traits connected to extinct bird species.
The announcement immediately triggered fascination, excitement, and concern across the scientific and tech communities because it pushes de-extinction science into a much more visible stage. This is no longer just about laboratory DNA experiments. There are now living animals involved.
Colossal says the chicks were developed using advanced gene-editing techniques that inserted traits inspired by extinct birds into modern chickens. The company described the development as a major step toward understanding how ancient characteristics can potentially be recreated through modern biotechnology.
The startup did not claim it had literally recreated dinosaurs or fully resurrected extinct birds. But the comparison to “Jurassic Park” spread quickly online because the visual reality of live chicks emerging from a project tied to extinct species immediately makes the science feel more tangible to ordinary people. And honestly, that psychological shift matters.
For years, de-extinction sounded distant and theoretical. Now people are beginning to see actual biological outcomes. Colossal Biosciences has become one of the most talked about startups in synthetic biology partly because of how ambitious its goals sound. The company previously announced projects linked to the woolly mammoth, the dodo bird, and the Tasmanian tiger, arguing that gene-editing technology can eventually help restore lost species or at least recreate important traits tied to them.
The company says the broader mission is not simply about spectacle or scientific curiosity. Instead, it argues the technologies being developed could help biodiversity conservation, endangered species recovery, and ecosystem restoration. “We’re developing technologies that can directly support conservation efforts happening today,” Colossal has repeatedly said in previous public statements about its research goals.
Still, critics remain deeply skeptical. Some scientists argue that true de-extinction is scientifically impossible because extinct species cannot be perfectly recreated once their original environmental and genetic conditions are gone forever. Others worry the industry is becoming overly commercialized, with dramatic headlines attracting investor attention faster than the underlying science can fully support.
And then there is the ethical side. The moment living animals enter the equation, public debate becomes much more emotional. Questions around animal welfare, long-term ecological consequences, and genetic experimentation immediately become harder to ignore.
Supporters see innovation. Critics see the possibility of science moving faster than regulation. The company itself appears very aware of those concerns. Colossal says the edited chicks are part of controlled research programs and not intended for public release or entertainment purposes.
But the cultural impact of the announcement is already significant. Because the phrase “de-extinction” no longer feels entirely abstract when people can actually look at living organisms connected to the process. The chicks were engineered with traits associated with extinct bird lineages, though the company has not fully disclosed every technical detail publicly yet.
That partial secrecy has also fueled curiosity online, especially among people fascinated by how far gene-editing technology has advanced over the past decade. The broader biotechnology industry is now entering an era where synthetic biology, CRISPR editing, and genomic engineering are rapidly moving from academic research into commercial startup ecosystems.
Investors are pouring money into companies focused on genetic medicine, food engineering, longevity science, synthetic organisms, and biodiversity technology. Colossal sits directly at the center of that movement because it combines cutting-edge biotechnology with something even more powerful:
Public imagination. And honestly, that may be why this story feels bigger than a normal science update. Most biotech breakthroughs are difficult for ordinary people to emotionally connect with. This one is different. The moment people hear “extinct species,” “gene editing,” and “live chicks” in the same sentence, the imagination immediately takes over. That is exactly why “Jurassic Park” keeps getting mentioned.
Not because scientists are building dinosaurs. But because the line between science fiction and real biotechnology suddenly feels less distant than before. At the same time, many researchers caution against exaggeration. The chicks are not ancient birds returning to life. They are genetically edited modern birds carrying selected engineered traits. That distinction is scientifically important. But culturally, the symbolism may already be impossible to separate from the bigger idea.
Humans are now entering a period where biotechnology is no longer only curing disease or improving crops. It is beginning to experiment with the genetic past itself. And whether people find that exciting or terrifying often depends on how comfortable they are with science crossing boundaries that once existed only inside movies.
